GGA’s Luis Navas speaks on Valeant Pharmaceuticals’ bid to triple market value

Luis H. Navas
Senior Partner / BBA, MBA

Luis Navas is a Senior Partner and Co-Founder at GGA and GGS, and is a…

GGA was back in the news in January with a story by the Financial Post’s Nick Van Praet, in regard to Montreal-based Valeant Pharmaceuticals’ bid to triple its current market value through a possible “game-changing, merger-of-equals …” deal. You can read Luis’s comments, along with the full story, here.

More Articles From This Author